Fabian Depis

Fabian Depis

Company: GentiBio

Job title: Director, Discovery Research

Seminars:

Generating EngTregs to Overcome Key Challenges Associated with the Successful Application of Treg Cell Therapeutics 11:30 am

Engineering abundant T cell populations with stabilized FOXP3 expression to create a scalable Treg Phenotype Utilizing an inducible chimeric receptor to provide highly specific and tunable IL-2 signaling support Providing tissue specificity and enhanced regulatory functions through antigenspecific CARs or TCRsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.